ZA200701081B - Selected fused heterocyclics and uses thereof - Google Patents
Selected fused heterocyclics and uses thereofInfo
- Publication number
- ZA200701081B ZA200701081B ZA200701081A ZA200701081A ZA200701081B ZA 200701081 B ZA200701081 B ZA 200701081B ZA 200701081 A ZA200701081 A ZA 200701081A ZA 200701081 A ZA200701081 A ZA 200701081A ZA 200701081 B ZA200701081 B ZA 200701081B
- Authority
- ZA
- South Africa
- Prior art keywords
- selected fused
- fused heterocyclics
- heterocyclics
- fused
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60239904P | 2004-08-18 | 2004-08-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200701081B true ZA200701081B (en) | 2008-08-27 |
Family
ID=35004223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200701081A ZA200701081B (en) | 2004-08-18 | 2007-02-06 | Selected fused heterocyclics and uses thereof |
Country Status (19)
Country | Link |
---|---|
US (1) | US20070249636A1 (de) |
EP (1) | EP1781673B1 (de) |
JP (1) | JP2008509976A (de) |
KR (1) | KR20070046175A (de) |
CN (1) | CN101023086A (de) |
AR (1) | AR050921A1 (de) |
AT (1) | ATE446301T1 (de) |
AU (1) | AU2005273704A1 (de) |
BR (1) | BRPI0514398A (de) |
CA (1) | CA2575056A1 (de) |
DE (1) | DE602005017283D1 (de) |
IL (1) | IL180811A0 (de) |
MX (1) | MX2007001954A (de) |
NO (1) | NO20070980L (de) |
RU (1) | RU2007109867A (de) |
TW (1) | TW200621260A (de) |
UY (1) | UY29074A1 (de) |
WO (1) | WO2006018627A1 (de) |
ZA (1) | ZA200701081B (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2575188A1 (en) | 2004-08-18 | 2006-02-23 | Astrazeneca Ab | Enantiomers of selected fused pyrimidones and uses in the treatment and preventi on of cancer |
DE602006015658D1 (de) * | 2005-06-27 | 2010-09-02 | Amgen Inc | Entzündungshemmende arylnitrilverbindungen |
EP3053584A1 (de) * | 2007-06-21 | 2016-08-10 | Neuronascent, INC. | Verfahren und zusammensetzungen zur stimulation der neurogenese und hemmung der neuronalen degeneration mit isothiazolopyrimidinonen |
HUE027443T2 (en) | 2007-09-10 | 2016-10-28 | Boston Biomedical Inc | A novel class of Stat3 pathway inhibitors and tumor stem cell inhibitors |
BRPI0818605A2 (pt) | 2007-10-19 | 2015-04-22 | Schering Corp | Derivados de 1,3,4-tiadiazl espiro-condensados para inibir a atividade de ksp cinesima |
SG11201508358RA (en) | 2013-04-09 | 2015-11-27 | Boston Biomedical Inc | 2-acetylnaphtho[2,3-b]furan -4,9-dione for use on treating cancer |
WO2018102427A1 (en) | 2016-11-29 | 2018-06-07 | Boston Biomedical, Inc. | Naphthofuran derivatives, preparation, and methods of use thereof |
CA3062656A1 (en) | 2017-05-17 | 2018-11-22 | Boston Biomedical, Inc. | Methods for treating cancer |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4464136B2 (ja) * | 2001-12-06 | 2010-05-19 | メルク・シャープ・エンド・ドーム・コーポレイション | 有糸分裂キネシン阻害薬 |
US7262187B2 (en) * | 2001-12-06 | 2007-08-28 | Merck & Co., Inc. | Substituted oxazolo- and thizaolopyrimidinones as a mitotic kinesin inhibitor |
PL211300B1 (pl) * | 2002-04-17 | 2012-05-31 | Cytokinetics Inc | Związek i kompozycja zawierająca ten związek |
MXPA05009577A (es) * | 2003-03-07 | 2005-12-12 | Astrazeneca Ab | Heterociclos fundidos novedosos y sus usos. |
US7022850B2 (en) * | 2003-05-22 | 2006-04-04 | Bristol-Myers Squibb Co. | Bicyclicpyrimidones and their use to treat diseases |
US7345046B2 (en) * | 2003-05-30 | 2008-03-18 | Chiron Corporation | Heteroaryl-fused pyrimidinyl compounds as anticancer agents |
-
2005
- 2005-08-16 AU AU2005273704A patent/AU2005273704A1/en not_active Abandoned
- 2005-08-16 AR ARP050103462A patent/AR050921A1/es unknown
- 2005-08-16 JP JP2007526564A patent/JP2008509976A/ja active Pending
- 2005-08-16 MX MX2007001954A patent/MX2007001954A/es not_active Application Discontinuation
- 2005-08-16 RU RU2007109867/04A patent/RU2007109867A/ru not_active Application Discontinuation
- 2005-08-16 KR KR1020077006175A patent/KR20070046175A/ko not_active Application Discontinuation
- 2005-08-16 CA CA002575056A patent/CA2575056A1/en not_active Abandoned
- 2005-08-16 WO PCT/GB2005/003202 patent/WO2006018627A1/en active Application Filing
- 2005-08-16 AT AT05771781T patent/ATE446301T1/de not_active IP Right Cessation
- 2005-08-16 US US11/573,671 patent/US20070249636A1/en not_active Abandoned
- 2005-08-16 EP EP05771781A patent/EP1781673B1/de active Active
- 2005-08-16 CN CNA2005800292545A patent/CN101023086A/zh active Pending
- 2005-08-16 BR BRPI0514398-5A patent/BRPI0514398A/pt not_active IP Right Cessation
- 2005-08-16 DE DE602005017283T patent/DE602005017283D1/de active Active
- 2005-08-17 UY UY29074A patent/UY29074A1/es not_active Application Discontinuation
- 2005-08-18 TW TW094128205A patent/TW200621260A/zh unknown
-
2007
- 2007-01-18 IL IL180811A patent/IL180811A0/en unknown
- 2007-02-06 ZA ZA200701081A patent/ZA200701081B/xx unknown
- 2007-02-21 NO NO20070980A patent/NO20070980L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR050921A1 (es) | 2006-12-06 |
KR20070046175A (ko) | 2007-05-02 |
JP2008509976A (ja) | 2008-04-03 |
EP1781673A1 (de) | 2007-05-09 |
IL180811A0 (en) | 2007-06-03 |
NO20070980L (no) | 2007-03-12 |
TW200621260A (en) | 2006-07-01 |
UY29074A1 (es) | 2006-03-31 |
US20070249636A1 (en) | 2007-10-25 |
CN101023086A (zh) | 2007-08-22 |
CA2575056A1 (en) | 2006-02-23 |
DE602005017283D1 (de) | 2009-12-03 |
WO2006018627A1 (en) | 2006-02-23 |
AU2005273704A1 (en) | 2006-02-23 |
RU2007109867A (ru) | 2008-09-27 |
EP1781673B1 (de) | 2009-10-21 |
ATE446301T1 (de) | 2009-11-15 |
BRPI0514398A (pt) | 2008-06-10 |
MX2007001954A (es) | 2007-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1802588A4 (de) | Substituierte aminopyrimidone und anwendungen davon | |
EP1831170A4 (de) | Substituierte aminopyridine und deren verwendung | |
EP1802587A4 (de) | Substituierte aminoverbindungen und deren anwendungen | |
PL1830872T3 (pl) | Białka fuzyjne | |
GB0426397D0 (en) | Fusion proteins | |
IL179300A0 (en) | Novel-antigen-binding polypeptides and their uses | |
IL182554A0 (en) | Anti-addl antibodies and uses thereof | |
EP1731134A4 (de) | Funktionale pulver | |
IL189609A0 (en) | 4-substituted pyrrolidin-2-ones and their use | |
IL178277A0 (en) | Irta-5 antibodies and their uses | |
IL180596A0 (en) | Field labeled button | |
HK1137439A1 (en) | Fused pyrrolocarbazoles and methods for the preparation thereof | |
EP1824467A4 (de) | Apogossypolon und dessen verwendungen | |
IL179497A0 (en) | Carboranylporphyrins and uses thereof | |
TWI315940B (en) | Improved tie-high and tie-low circuit | |
HK1084390A1 (en) | Fused heterocycles and uses thereof | |
ZA200701081B (en) | Selected fused heterocyclics and uses thereof | |
ZA200703406B (en) | Anti-ADDL antibodies and uses thereof | |
PL2215908T3 (pl) | 2-alkilo-cykloalk(en)ylo-karboksamidy i ich zastosowanie jako fungicydów | |
EP1737565A4 (de) | Cos-claus-konfigurationen und -verfahren | |
IL180365A0 (en) | Carboranylporphyrins and uses thereof | |
EP1943350A4 (de) | Latente procytotoxine und anwendungen davon | |
EP1761256A4 (de) | Cla-angereichertes milchfett und seine verwendungen | |
ZA200605668B (en) | Fused pyrrolocarbazoles and methods for the preparation thereof | |
TWI365449B (en) | Case member and cartridge |